Medical Devices Series B Investors & VC Firms
515 firms in this list, with a median first check of $540K. 108 of them lead rounds. Generated from verified public data and updated continuously.
MB Venture Partners
MemphisPre-Seed–Growth
2 people
Aescuvest
Frankfurt am MainSeed–Series B
1 person
Asclepius Life Sciences Fund, LP
New YorkSeed–Series B
3 people
Long Hill Capital
Grand CaymanSeries A–Growth
3 people
Gaorong Capital
BeijingSeed–Series B
5 people
Strategic Investment Partners Inc.
TokyoSeed–Growth
2 people
KSP, Inc.
KawasakiSeed–Series B
1 person
Comway Capital Ltd.
ShanghaiSeed–Series B
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Shunya Ventures
Seed–Series B
2 people
StarChain Ventures
Silicon ValleyPre-Seed–Series B
2 people
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Growth
1 person
Boxer Capital, LLC
San DiegoSeed–Late Stage
1 person
New Age Ventures
New YorkPre-Seed–Series B
1 person
TriWise Capital
ShenzhenPre-Seed–Series B
1 person
YFY Biotech Management Company
TaipeiSeed–Series B
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Nissay Capital
TokyoPre-Seed–Growth
1 person
Aflac Ventures Japan
TokyoSeed–Growth
7 people
Stonebridge Ventures
SeoulSeries A–Series C
3 people
CIBC
TorontoPre-Seed–Late Stage$1.5M – $29.2M
1 person
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
ePlanet Capital
San JoseSeed–Late Stage
3 people
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
Related lists
Series B Investors & VC Firms (2954)Series B Investors & VC Firms in North America (1744)Medical Devices Investors & VC Firms (1659)Series B Investors & VC Firms in United States (1578)Medical Devices Seed Investors & VC Firms (1321)Medical Devices Series A Investors & VC Firms (1139)Medical Devices Investors & VC Firms in North America (1090)Series B Investors & VC Firms in Europe (1078)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Global (1068)
Data sourced from public filings and firms' own websites — see our methodology.

















